Tirzepatide Brand NEW

Tirzepatide is a novel dual GIP/GLP-1 receptor agonist that leverages two incretin pathways simultaneously, representing a breakthrough in metabolic regulation through unimolecular dual agonism.

• Tirzepatide demonstrates balanced activation of both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, producing synergistic effects on insulin secretion, glucagon suppression, and appetite regulation beyond single-pathway activation.

• Research shows superior metabolic outcomes with up to 20.9% weight reduction and 2.4% HbA1c reduction in clinical models, exceeding results from selective GLP-1 agonists alone.

• Studies reveal unique effects on lipid metabolism with 25% triglyceride reduction and significant hepatic fat clearance through combined incretin signaling and enhanced insulin sensitivity.

Tirzepatide achieves dual incretin activation, unprecedented weight loss, and comprehensive metabolic improvement, offering researchers a next-generation tool for investigating obesity, type 2 diabetes, and metabolic syndrome.

Composition: Tirzepatide (15 mg, 30mg)

Leading Research Peptide: Tirzepatide –  99% Pure

Explore the forefront of metabolic research with Tirzepatide, an advanced dual GIP and GLP-1 receptor agonist peptide. Meticulously synthesized to the highest purity standards, Tirzepatide is an indispensable tool for scientists investigating complex metabolic pathways, glucose regulation, appetite control, and body weight management. Our  peptide is provided in a lyophilized powder form, ensuring optimal stability and readiness for your critical laboratory experiments.

Tirzepatide: A Dual Agonist for Metabolic Research:

Tirzepatide represents a significant advancement in peptide research, simultaneously targeting both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism offers a unique avenue for researchers to study its profound effects on insulin secretion, glucose disposal, energy expenditure, and satiety. Its comprehensive action makes it a key compound for studies aiming to understand and potentially influence metabolic health.

Key Features for Researchers:

• Exceptional Purity: Offered at  99% purity, guaranteeing the integrity and reliability of your research findings.
• Lyophilized Powder Format: Supplied as a sterile, lyophilized powder in a vial, ensuring superior stability and ease of storage. Reconstitution is required prior to experimental use.
• Cutting-Edge Metabolic Research: An essential peptide for studies in endocrinology, obesity research, diabetes research, and the development of novel metabolic therapies.
• Rigorous Quality Control: Each batch undergoes strict testing to meet the demanding requirements of research-grade peptides.
• Available in Various Research Quantities: Typically offered in quantities such as 5mg, 10mg, or larger vials to accommodate diverse research protocols.

This Tirzepatide peptide is intended strictly for laboratory research use by qualified scientific professionals. It is not intended for human or animal consumption, nor for any therapeutic, diagnostic, or other applications. Always handle research chemicals with the utmost care and adhere to all established laboratory safety protocols.

Product Specifications:

• Peptide Name: Tirzepatide
• Purity: 99%
• Form: Lyophilized Powder
• Storage: For optimal preservation, store the lyophilized powder in a cool, dry place, ideally refrigerated or frozen. Reconstituted solutions should be refrigerated and used within the specified timeframe.
• Intended Use: For Laboratory Research Only.